Correlation Between Virtus LifeSci and Loncar Cancer
Can any of the company-specific risk be diversified away by investing in both Virtus LifeSci and Loncar Cancer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virtus LifeSci and Loncar Cancer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virtus LifeSci Biotech and Loncar Cancer Immunotherapy, you can compare the effects of market volatilities on Virtus LifeSci and Loncar Cancer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virtus LifeSci with a short position of Loncar Cancer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virtus LifeSci and Loncar Cancer.
Diversification Opportunities for Virtus LifeSci and Loncar Cancer
0.94 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Virtus and Loncar is 0.94. Overlapping area represents the amount of risk that can be diversified away by holding Virtus LifeSci Biotech and Loncar Cancer Immunotherapy in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Loncar Cancer Immuno and Virtus LifeSci is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virtus LifeSci Biotech are associated (or correlated) with Loncar Cancer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Loncar Cancer Immuno has no effect on the direction of Virtus LifeSci i.e., Virtus LifeSci and Loncar Cancer go up and down completely randomly.
Pair Corralation between Virtus LifeSci and Loncar Cancer
Considering the 90-day investment horizon Virtus LifeSci Biotech is expected to generate 1.08 times more return on investment than Loncar Cancer. However, Virtus LifeSci is 1.08 times more volatile than Loncar Cancer Immunotherapy. It trades about -0.19 of its potential returns per unit of risk. Loncar Cancer Immunotherapy is currently generating about -0.29 per unit of risk. If you would invest 2,697 in Virtus LifeSci Biotech on September 24, 2024 and sell it today you would lose (248.56) from holding Virtus LifeSci Biotech or give up 9.22% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Strong |
Accuracy | 95.24% |
Values | Daily Returns |
Virtus LifeSci Biotech vs. Loncar Cancer Immunotherapy
Performance |
Timeline |
Virtus LifeSci Biotech |
Loncar Cancer Immuno |
Virtus LifeSci and Loncar Cancer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Virtus LifeSci and Loncar Cancer
The main advantage of trading using opposite Virtus LifeSci and Loncar Cancer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virtus LifeSci position performs unexpectedly, Loncar Cancer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Loncar Cancer will offset losses from the drop in Loncar Cancer's long position.Virtus LifeSci vs. Virtus LifeSci Biotech | Virtus LifeSci vs. ALPS Medical Breakthroughs | Virtus LifeSci vs. Loncar Cancer Immunotherapy |
Loncar Cancer vs. Virtus LifeSci Biotech | Loncar Cancer vs. Virtus LifeSci Biotech | Loncar Cancer vs. ALPS Medical Breakthroughs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |